Published on

Therapy for Cannabis Use Disorder: What the Trials Show

Authors

Clinical standard

Written to a clinical standard reviewed by Dr. Lu Chong · Medical oncology · Health examination and preventive care. This article was not individually reviewed — what that means.

Two empty chairs facing each other in a quiet, softly lit consulting room

Therapy for cannabis use disorder means one of four things in practice: cognitive behavioural therapy, motivational enhancement therapy, contingency management, or a combination of the first two. NIDA names cognitive behavioural therapy, motivational enhancement therapy and contingency management as behavioural interventions that can be effective, and states there are no FDA-approved medications for the treatment of cannabis use disorder or for medically assisted withdrawal. Talking treatment is not one option among several. It is the option.

What the evidence supports is more modest than most treatment pages suggest, and knowing the real numbers before you start is the difference between a realistic plan and a disappointment.

What the best available evidence actually found

The reference point is a Cochrane review of psychosocial interventions for cannabis use disorder. It pooled 23 randomised controlled trials involving 4,045 participants, comparing CBT, motivational enhancement therapy, the two combined, contingency management, social support, mindfulness-based meditation and drug counselling.

The headline result: people who received an intervention used cannabis on fewer days, used fewer joints per day, and reported fewer symptoms of dependence and fewer cannabis-related problems than people who did not.

The qualifier matters as much. Abstinence rates were low across the board — around one quarter of participants were abstinent at final follow-up — and the review rated the certainty of the evidence as moderate for frequency of cannabis use and low for abstinence. Reduction is the outcome therapy reliably moves. Stopping altogether is the outcome it moves least.

That is not an argument against therapy. It is an argument against expecting a course of it to do the whole job, and for treating whatever it gives you as a head start rather than a finish.

The four approaches, and what each one involves

Cognitive behavioural therapy

CBT is the best-studied of the four. In NIDA's description, cognitive-behavioural therapy seeks to help patients recognise, avoid and cope with the situations in which they are most likely to use drugs.

In practice that means mapping your own triggers, building specific responses to each one, and testing them between sessions. It is homework-heavy and unsentimental. What CBT for quitting weed involves session by session goes through the mechanics.

Motivational enhancement therapy

Shorter, and aimed at a different problem: ambivalence. Most people who use cannabis heavily are not certain they want to stop, and a technique that assumes commitment will not work on someone who has not made one.

MET works on that uncertainty directly rather than treating it as a lack of willpower. In the Cochrane data it produced smaller reductions in days of use than CBT on its own, which is roughly what you would expect from a briefer intervention.

The combination

MET followed by CBT is the pairing that appears most consistently in the trials, and it is the one clinicians most often deliver. The logic is sequential: resolve whether you want to change, then build the skills to do it.

Contingency management

Contingency management is the outlier, because it does not involve talking about anything. It uses positive reinforcement such as providing rewards or privileges for remaining drug-free — in cannabis trials, usually vouchers for negative urine tests.

It works, and it is the approach most people have never been offered, because paying patients for test results is difficult to fund in routine services. Where it exists, it is generally attached to a specialist programme.

Start counting clean days with Dehaze

Dehaze tracks every clean day, walks you through cravings with guided breathing, and adds up the money and hours you get back. Free to start, private by default.

Download Dehaze on iOS

Intensity matters more than the brand of therapy

The most actionable finding in the Cochrane review is not about which therapy wins. It is about dose. Interventions of more than four sessions delivered over longer than one month produced consistently improved outcomes compared with low-intensity interventions.

Four sessions in a month is a low bar that a lot of real-world treatment does not clear. A single assessment appointment and a leaflet is not a course of therapy, and the evidence does not support expecting much from it.

The same pattern shows up when people compare what a marijuana addiction treatment programme actually offers: the length and frequency of contact predict outcomes better than the label on the door.

Where combining treatments stops helping

It would be neat if stacking approaches stacked their effects. It does not reliably work that way.

A 12-week randomised trial of 127 treatment-seeking young adults, most referred through the criminal justice system, tested CBT alone, CBT plus contingency management for homework and attendance, contingency management for abstinence alone, and contingency management for abstinence plus CBT. Contrary to the hypothesis, contingency management for abstinence alone produced the highest mean number of consecutive cannabis-free urine specimens, and adding CBT to it worsened rather than improved the result. The authors concluded that combining the two did not appear to improve success rates in that population.

One trial in one group of people does not overturn a review of 23. What it does is set a limit on how confidently anyone can prescribe a specific combination for a specific person. More therapy is not automatically better therapy, and a clinician who tells you the evidence is settled is overstating it.

How to choose, and how to get it

A workable order:

  1. Confirm what you are treating. Cannabis use disorder is a graded diagnosis in the DSM-5, not a yes-or-no verdict. The eleven questions clinicians ask will tell you roughly where you sit, which changes how much structure you need.
  2. Start with your doctor, not a directory. They can refer, rule out what is not cannabis, and treat a co-occurring condition that would otherwise undo the work. What to say when you raise it is shorter than most people expect.
  3. Ask for MET plus CBT by name, and ask how many sessions. If the answer is fewer than four over a month, ask what else is available.
  4. Search the directory if there is no doctor. In the US, FindTreatment.gov lists licensed treatment facilities by location and service type.
  5. Do not wait for an appointment to start. Tracking triggers, protecting sleep and having a plan for the first fortnight all work before therapy begins. A practical method for quitting covers the self-directed version, and tapering rather than stopping abruptly is worth considering while you wait.

What therapy will not do

It will not remove withdrawal. The first two weeks after you stop follow their own course regardless of what treatment you are in — symptoms peak in the first few days and ease over the following weeks, with sleep lagging behind. What day 6 typically looks like is the same whether or not you have a therapist.

It will not make relapse impossible either, and a return to use is not a sign the treatment failed. NIDA puts relapse rates for substance use disorders at 40 to 60%, similar to rates for other chronic illnesses such as hypertension and asthma, and describes relapse as a sign for resumed, modified or new treatment rather than an ending.

When to get help sooner rather than researching longer

Some situations should not wait for a referral: withdrawal that is severe or getting worse, stopping alcohol or benzodiazepines at the same time, psychosis, hallucinations or severe paranoia, persistent vomiting, pregnancy, a mental health condition that is deteriorating, or any thought of self-harm.

In the US, SAMHSA's National Helpline is free, confidential, and open 24/7 at 1-800-662-4357. If you are in immediate danger, call your local emergency number.

Therapy for cannabis use disorder is a real treatment with real, measured, moderate effects. Go in expecting fewer days of use and a better set of tools, ask for enough sessions to clear the bar the evidence sets, and treat anything beyond that as a bonus rather than the plan.

Sources

Frequently Asked Questions

What therapy is used for cannabis use disorder?

Mainly four approaches: cognitive behavioural therapy, motivational enhancement therapy, contingency management, and the combination of motivational enhancement therapy with CBT. NIDA names CBT, motivational enhancement therapy and contingency management as behavioural interventions that can be effective. There is no medication approved for the condition.

Does therapy actually work for cannabis use disorder?

It helps, without being a solution for most people. A Cochrane review of 23 randomised trials covering 4,045 participants found people who received an intervention used cannabis on fewer days and reported fewer dependence symptoms, but roughly one quarter were abstinent at final follow-up. The evidence was rated moderate for frequency of use and low for abstinence.

How many therapy sessions do you need to quit weed?

More than four, spread over more than a month. The Cochrane review found that higher-intensity interventions of more than four sessions delivered over longer than one month produced consistently better outcomes than shorter ones. A single session is unlikely to change much on its own.

What is the difference between CBT and motivational enhancement therapy?

CBT teaches you to recognise, avoid and cope with the situations where you are most likely to use. Motivational enhancement therapy is shorter and works on ambivalence — resolving whether you want to change at all. The two are often delivered together, and the combination was among the most consistently effective in the Cochrane review.

Is contingency management available outside research studies?

Access is limited. Contingency management pays or rewards you for drug-free test results, which is well supported in trials but awkward to fund in routine care. Where it exists it is usually attached to a specialist programme rather than offered by an individual therapist.

Do I need therapy or can I quit on my own?

Many people stop without formal treatment, and trying alone first is reasonable if use is not severe and there is no other substance, mental health condition or pregnancy involved. Therapy is worth pursuing if you have tried and stalled repeatedly, or if quitting is affecting your mental health.

A note on this article

This is information and peer support, not medical advice, diagnosis, or treatment. Dehaze is a self-directed tracking app, not a treatment programme, and nothing here replaces guidance from a clinician who knows your history. If withdrawal is severe, if you are using cannabis alongside other substances, or if you are managing a mental health condition at the same time, please talk to a professional.

In the US, SAMHSA’s National Helpline is free, confidential, and open 24/7 at 1-800-662-4357. If you are in immediate danger, call your local emergency number. Spot something inaccurate here? Tell us.

Discuss on X